Karen Meyer
Pediatrics · Omaha, NENPI 1255448759
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 67 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 13.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $262 and has fallen 89.0% since, to $29 in 2023.
Across 67 payments — averaging $14.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$133
- Novo Nordisk$127
- Johnson & Johnson$100
- Otsuka America Pharmaceutical, Inc.$80
- Takeda Pharmaceuticals U.S.A., Inc.$47
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$39
- plus $440 from 21 others
What the payments were for
- Food & beverage$965100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 10 | $133 |
| Novo Nordisk | 8 | $127 |
| Johnson & Johnson | 7 | $100 |
| Otsuka America Pharmaceutical, Inc. | 5 | $80 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $47 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $39 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $32 |
| Boehringer Ingelheim | 2 | $32 |
| Amarin Pharma, Inc. | 2 | $31 |
| AstraZeneca | 2 | $31 |
| Nalpropion Pharmaceuticals LLC | 2 | $27 |
| Tris Pharma Inc | 2 | $27 |
| Vertical Pharmaceuticals, LLC | 2 | $27 |
| Genentech USA, Inc. | 2 | $26 |
| Pfizer | 2 | $26 |
| Eisai Inc. | 2 | $24 |
| Boston Scientific | 1 | $16 |
| Circassia Inc. | 1 | $16 |
| Sobi, Inc | 1 | $16 |
| Biohaven Pharmaceuticals, Inc. | 1 | $16 |
| Antares Pharma, Inc. | 1 | $15 |
| Ironshore Pharmaceuticals Inc. | 1 | $14 |
| Merck | 1 | $14 |
| Axsome Therapeutics, Inc. | 1 | $13 |
| Bausch Health US, LLC | 1 | $13 |
| Sanofi Pasteur Inc. | 1 | $13 |
| GSK | 1 | $12 |
How this compares
$965 in reported general payments places this provider in the 80th percentile of 308 pediatrics providers in Nebraska.
Other pediatrics in Omaha
- Sachit PatelOmaha$91K
- Rachel AndersonOmaha$76K
- Amy LacroixOmaha$40K
- Hana NieburOmaha$25K
- Melissa Muff-LuettOmaha$16K
- Karl RothOmaha$12K
- Danita VelascoOmaha$11K
- Rachel TaylorOmaha$10K
- Philip BoucherOmaha$10K
- Bernard DouglasOmaha$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.